Manipulating Ghrelin signaling via GOAT inhibition in alcohol use disorder.
Award Notice Posted
- Solicitation number
- 75N95022Q00400
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Alcami Carolinas Corporation
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95022P00407 Federal contract award
- NAICS code
- 541380 Testing Laboratories and Services
- Place of performance
- Baltimore, Maryland, United States
Notice details come from SAM.gov. Updated .
Notice text
For purchases not exceeding the simplified acquisition threshold, contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name or industrial mobilization). This contract WAS awarded to Alcami Carolinas Corporation, 2320 Scientific Park DR, Wilmington, North Carolina 28405, to perform the stability testing on the ongoing study drug GLWL-01 in relation to alcohol related behavior.
Awarded contract 75N95022P00407 to Alcami Carolinas Corporation for 68210.00 on 2022-08-05.
Files
| File | Type | Posted |
|---|---|---|
| B. SSJ_signed.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Manipulating Ghrelin signaling via GOAT inhibition in alcohol use disorder. | Special Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity